DrugPatentWatch Database Preview
Litigation Details for Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc. (D. Del. 2013)
Email this page to a colleague
See Plans and PricingAuxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc. (D. Del. 2013)
| Docket | Start Trial | Date Filed | 2013-01-28 |
| Court | District Court, D. Delaware | Date Terminated | 2013-12-30 |
| Cause | 28:1338 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | |
| Parties | AUXILIUM PHARMACEUTICALS INC.; FCB I LLC; UPSHER-SMITH LABORATORIES INC. | ||
| Patents | 5,023,252; 6,010,718; 6,319,913; 7,214,381; 7,320,968; 7,608,605; 7,608,606; 7,608,607; 7,608,608; 7,608,609; 7,608,610; 7,935,690; 8,063,029; 8,178,518 | ||
| Attorneys | Andrew Colin Mayo; Anne Shea Gaza; Lauren E. Maguire; Steven J. Balick; Travis Steven Hunter | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , and Start Trial .
Biologic Drugs cited in Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc.
The biologic drug covered by the patents cited in this case is Start Trial .
Details for Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc. (D. Del. 2013)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2013-01-28 | 1 | infringement of U.S. Patent Nos. 7,320,968 (the “’968 Patent”); 7,608,605 (the “’605 Patent”); 7,608,606 (the…’968 Patent; the ’605 Patent; the ’606 Patent; the ’607 Patent; the ’608 Patent; the ’609 Patent; the…’968 Patent, the ’605 Patent, the ’606 Patent, the ’607 Patent, the ’608 Patent, the ’609 Patent, the…the ’610 Patent; the ’690 Patent; the ’029 Patent; and the ’518 Patent in the Orange Book—formally known…the ’610 Patent, the ’690 Patent, the ’029 Patent, and the ’518 Patent. COUNT I | External link to document | |
| 2013-12-04 | 120 | Hsieh (U.S. Patent No. 5,023,252 -hereafter "the Hsieh patent"). …enhancer of the type described in U.S. Pat. No. 5,023,252 to Hsieh" ("Hsieh enhancer"). The…type described in U.S. Pat. No. 5,023,252 to Hsieh (assigned to the same assignee as that…the '518 patent, '605 patent, '606 patent, '607 patent, and '609 patent are similarly…'518 patent, 24:14-15; '605 patent, 23:12; '606 patent, 23:39; '607 patent, 23:39, 24 | External link to document | |
| 2013-12-30 | 125 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,320,968 B2; 7,608,605 B2; 7,608,606… 30 December 2013 1:13-cv-00148-SLR Patent None District Court, D. Delaware | External link to document | |
| 2013-01-28 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,320,968 B2; 7,608,605 B2; 7,608,606… 30 December 2013 1:13-cv-00148-SLR Patent None District Court, D. Delaware | External link to document | |
| 2013-05-10 | 52 | tenth patent, all listed in the Orange Book for TESTIM. The first, U.S. Patent No. 7,320,968 (the ’968…apply to two of the patents-in- suit, the ’608 Patent and the ’610 Patent. These patents are continuations…“’606 Patent”); 7,608,607 ( “’607 Patent”); 7,608,608 ( “’608 Patent”); 7,608,609 ( “’609 Patent”); 7,…610 Patent”); 7,935,690 ( “’690 Patent”); 8,063,029 (“’029 Patent”); and 8,178,518 ( “’518 Patent”). (…invention claimed in a 2003 patent, U.S. Patent No 6,503,894, the “Dudley patent.” (Taavola Decl. Ex. 41 | External link to document | |
| 2013-05-24 | 66 | disclosure and the teachings of the Hsieh patent (U.S. Patent `No. 5,023,252), Gyuril< has only been ailowcd…Dudley et al. (U.S. Patent No` 6,503,894) in view of Hsieh (U.S. Patent No. 5,023,252).” D.l. 58-11 at CPBX0115373…of the ’968 patent, ’605-’607 patent, ’609 patent, ’690 patent ’029 patent, and ’513 patent Augusrine Mea….S. Patent No. 5,968,919 (on which Gyurik is a named inventor) and the Dudley patent (U.S. Patent No, … reference, citations are to the ’968 patent (the parent patent) specification which is substantialiy | External link to document | |
| 2013-07-03 | 75 | thereof.” Id. at 1208 (quoting U.S. Pat. No. 6,010,718, at 3:65–67, {00765827;v1 } …foreseeable. 356 F.3d 1357, 1360 (Fed. Cir. 2004). The patent-in-suit claimed a sustained release formulation…class of compounds. In that case, the relevant patent claimed extended release formulations comprising… prove at trial that USL infringes Plaintiffs’ patents under the doctrine of equivalents. There are also…court’s grant of a preliminary injunction where the patent claimed either a mono- or disaccharide and the | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
